NCEL Stock Analysis: Buy, Sell, or Hold?
$2.63
0.13 (5.20%)
▲
5d:
-9.43%
30d:
-16.51%
90d:
-30.97%
WAIT
LOW Confidence
Analysis Updated: Oct 16, 2026 12:00 AM ET
Earnings: Jul 30, 2026
0d
Get Alerted When NCEL Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: NCEL shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: NCEL shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: NCEL is currently trading at $2.63, which is considered oversold relative to its 30-day fair value range of $2.77 to $3.23.
Technical Outlook: Technically, NCEL is in a downtrend. Immediate support is located at $2.36, while resistance sits at $3.28. The stock is showing strong short-term momentum, up 5.2% recently.
Market Sentiment: The stock scores a mixed 40/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $23.00 (+820.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, NCEL is in a downtrend. Immediate support is located at $2.36, while resistance sits at $3.28. The stock is showing strong short-term momentum, up 5.2% recently.
Market Sentiment: The stock scores a mixed 40/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $23.00 (+820.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$2.77 -
$3.23
Company Quality Score
42/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
87.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+5.2%)
- BULLISH: Trading 820.0% below Wall St target ($23.00)
- WARNING: Composite score 42/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$2.77 -
$3.23
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$2.36
Resistance Level
$3.28
Current Trend
Downtrend
Technical data as of
Oct 19, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-4.17
Wall Street Target
$23.00
(+820.0%)
Share & Embed Analysis
Last updated: October 19, 2026 3:57 PM ET
Data refreshes hourly during market hours. Next update: 4:57 PM
Data refreshes hourly during market hours. Next update: 4:57 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NCEL showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
24 analysts |
$139 | 68 BUY |
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
28 analysts |
$92 | 62 BUY |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
23 analysts |
$108 | 60 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
22 analysts |
$283 | 51 HOLD |
|
INCY
Incyte Corporation |
HOLD
28 analysts |
$130 | 71 BUY |